Despite statements by the American president, Barack Obama, that he hasn’t got the necessary information to give the “green light” for drug approval by the deadly Ebola virus, the Food and Drug Administration gave approval for partial use.
According to international networks, the responsible agency announced the partial approval of the drug for TKM-Ebola for a limited experimental use in people who carry the virus.
The representative of the Canadian pharmaceutical company Tekmira Pharmaceuticals, Mark Murray stated that: “We are pleased that the Food and Drug Administration reviewed the effectiveness of TKM-Ebola for infected patients”.

After the “green light” the company’s shares skyrocketed  by 20% in the early hours of Friday, a figure that was last seen last April.

Indeed, the shares of investors rose by 40% in recent days after the drug against the virus became known worldwide.
However, shares fell again once the head of Emory Hospital in Atlanta where two hospitalized Americans are infected with Ebola, informed that the drug used for the treatment was of another company.
As noted by international networks, investors believe that the drug can bring huge profits to the company.
According to CNN the Tekmira Pharmaceuticals has already signed a contract of 140 million dollars with the central government’s Ministry of Defense to prepare the TKM-Ebola.